The NLRP3 Inflammasome is a Therapeutic Target for Precision Medicine in Chronic Inflammatory Diseases: Fibrosis to Cancer

Time: 3:00 pm
day: Day 2 - Track B - Afternoon

Details:

  • An NME drug homolog of the NLRP3 regulator
  • Chronic inflammatory disease platform
  • Therapeutic relevance in cancer

Speakers: